Ishioka J - Search Results

1

Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors.

Ishioka J, Fujii Y, Kageyama Y, Fukuda H, Higashi Y, Kihara K. Ishioka J, et al. Int J Urol. 2008 Jul;15(7):642-5. doi: 10.1111/j.1442-2042.2008.02066.x. Int J Urol. 2008. PMID: 18643784

2

Clinical outcome of chemoradiotherapy for T1G3 bladder cancer.

Inoue M, Ishioka J, Fukuda H, Kageyama Y, Saito Y, Higashi Y. Inoue M, et al. Among authors: ishioka j. Int J Urol. 2008 Aug;15(8):747-50. doi: 10.1111/j.1442-2042.2008.02077.x. Int J Urol. 2008. PMID: 18786198

3

[Result of treatment for advanced germ cell tumor in the last decade].

Ishioka J, Kageyama Y, Inoue M, Fukui N, Numao N, Saito K, Ichiyanagi N, Tanak M, Hyochi N, Fukuda H, Higashi Y. Ishioka J, et al. Nihon Hinyokika Gakkai Zasshi. 2010 Mar;101(3):539-46. doi: 10.5980/jpnjurol.101.539. Nihon Hinyokika Gakkai Zasshi. 2010. PMID: 20387513 Japanese.

4

Impact of renal function on cardiovascular events in patients undergoing radical nephrectomy for renal cancer.

Takeshita H, Yokoyama M, Fujii Y, Chiba K, Ishioka J, Noro A, Kihara K. Takeshita H, et al. Among authors: ishioka j. Int J Urol. 2012 Aug;19(8):722-8. doi: 10.1111/j.1442-2042.2012.03015.x. Epub 2012 Apr 4. Int J Urol. 2012. PMID: 22487379

5

Treatment outcome of patients with extragonadal nonseminomatous germ cell tumors: the Saitama Cancer Center experience.

Fukui N, Kohno Y, Ishioka J, Fukuda H, Kageyama Y, Higashi Y. Fukui N, et al. Among authors: ishioka j. Int J Clin Oncol. 2013 Aug;18(4):731-4. doi: 10.1007/s10147-012-0436-2. Epub 2012 Jul 5. Int J Clin Oncol. 2013. PMID: 22763659

6

Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy for peripheral renal tumors: perioperative outcomes.

Kihara K, Koga F, Fujii Y, Masuda H, Tatokoro M, Yokoyama M, Matsuoka Y, Numao N, Ishioka J, Saito K. Kihara K, et al. Among authors: ishioka j. Int J Urol. 2015 Apr;22(4):349-55. doi: 10.1111/iju.12687. Epub 2015 Jan 13. Int J Urol. 2015. PMID: 25586116

7

Incorporation of TIP (paclitaxel, ifosfamide, cisplatin) into first-line therapy for intermediate to poor risk testicular germ cell tumors with unfavorable marker decline after initial two cycles chemotherapy: a report of three cases.

Ishioka J, Kageyama Y, Ichiyanagi N, Fukuda H, Higashi Y. Ishioka J, et al. Int J Urol. 2007 May;14(5):455-7. doi: 10.1111/j.1442-2042.2007.01755.x. Int J Urol. 2007. PMID: 17511735

8

[Bladder preservation by chemoradiotherapy in combination with radical TUR-Bt in muscle invasive bladder cancer].

Ishioka J, Kageyama Y, Ichiyanagi N, Saito Y, Nozu S, Nishida K, Fukuda H, Higashi Y. Ishioka J, et al. Nihon Hinyokika Gakkai Zasshi. 2007 Sep;98(6):752-6. doi: 10.5980/jpnjurol1989.98.752. Nihon Hinyokika Gakkai Zasshi. 2007. PMID: 17929456 Free article. Japanese.

9

[Primary malignant melanoma of the male urethra: a case report].

Inoue M, Ishioka J, Kageyama Y, Fukuda H, Higashi Y. Inoue M, et al. Among authors: ishioka j. Hinyokika Kiyo. 2008 Apr;54(4):305-8. Hinyokika Kiyo. 2008. PMID: 18516927 Free article. Japanese.

10

Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.

Ishioka J, Kageyama Y, Inoue M, Higashi Y, Kihara K. Ishioka J, et al. J Urol. 2008 Aug;180(2):618-21; discussion 621. doi: 10.1016/j.juro.2008.04.011. Epub 2008 Jun 12. J Urol. 2008. PMID: 18554655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters